18 related articles for article (PubMed ID: 34563340)
1. Causes of death and associated factors with death after liver transplantation: a nationwide database study.
Yoon J; Kim H; Choi D; Park B
HPB (Oxford); 2024 Jan; 26(1):54-62. PubMed ID: 37775353
[TBL] [Abstract][Full Text] [Related]
2. Debating the indication: re-transplant for patients whose initial transplant indication was hepatocellular carcinoma.
Akabane M; Melcher ML; Sasaki K
HPB (Oxford); 2023 Dec; 25(12):1600-1602. PubMed ID: 37633744
[No Abstract] [Full Text] [Related]
3. Pretransplant predictors of early mortality in adult recipients of liver transplantation in the MELD-Na Era.
Pozo-Laderas JC; Rodríguez-Perálvarez M; Muñoz-Villanueva MC; Rivera-Espinar F; Durban-García I; Muñoz-Trujillo J; Robles-Arista JC; Briceño-Delgado J
Med Intensiva (Engl Ed); 2019; 43(5):261-269. PubMed ID: 29735173
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
5. Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients.
Salgia RJ; Goodrich NP; Marrero JA; Volk ML
Dig Dis Sci; 2014 Jan; 59(1):214-9. PubMed ID: 24077924
[TBL] [Abstract][Full Text] [Related]
6. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
7. Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation.
Orci LA; Berney T; Majno PE; Lacotte S; Oldani G; Morel P; Mentha G; Toso C
Br J Surg; 2015 Sep; 102(10):1250-7. PubMed ID: 26098966
[TBL] [Abstract][Full Text] [Related]
8. Early postoperative mortality in liver transplant recipients involving indications other than hepatocellular carcinoma. A retrospective cohort study.
Pozo-Laderas JC; Guler I; Rodríguez-Perálvarez M; Robles JC; Mula A; López-Cillero P; de la Fuente C
Med Intensiva (Engl Ed); 2021 Oct; 45(7):395-410. PubMed ID: 34563340
[TBL] [Abstract][Full Text] [Related]
9. Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma.
Sposito C; Cucchetti A; Mazzaferro V
Dig Dis Sci; 2019 Apr; 64(4):1001-1007. PubMed ID: 30852770
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]